IRadimed Corp
F:46K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IRadimed Corp
F:46K
|
US |
|
A
|
Azarga Metals Corp
OTC:EUUNF
|
CA |
|
Fimperkasa Utama Tbk PT
IDX:FIMP
|
ID |
|
Rosseti Moskovskiy Region PAO
MOEX:MSRS
|
RU |
|
Nexcom A/S
F:8XT
|
DK |
|
Iren SpA
OTC:IRDEF
|
IT |
|
G
|
Giordano International Ltd
XMUN:GIO
|
HK |
Wall St Price Targets
46K Price Targets Summary
IRadimed Corp
According to Wall Street analysts, the average 1-year price target for 46K is 88.09 EUR with a low forecast of 85.75 EUR and a high forecast of 92.22 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 46K's stock price target?
Price Target
88.09
EUR
According to Wall Street analysts, the average 1-year price target for 46K is 88.09 EUR with a low forecast of 85.75 EUR and a high forecast of 92.22 EUR.
What is the Revenue forecast for IRadimed Corp?
Projected CAGR
11%
Over the last 12 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for IRadimed Corp?
Projected CAGR
12%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for IRadimed Corp?
Projected CAGR
13%
Over the last 12 years, the compound annual growth rate for Operating Income has been 20%. The projected CAGR for the next 3 years is 13%.
What is the Pre-Tax Income forecast for IRadimed Corp?
Projected CAGR
16%
Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 21%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for IRadimed Corp?
Projected CAGR
16%
Over the last 12 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 3 years is 16%.
